15 reports

  • RESPIRATORY DISORDERS THERAPEUTICS MARKET, GLOBAL, FORECAST REVENUE BY COMPANY, 2016-2023
  • RESPIRATORY DISORDERS THERAPEUTICS MARKET, GLOBAL, COMPANY ANALYSIS MATRIX, 2016-

THERE IS ONE THERAPY IN THE PIPELINE, SOLITHERA, DEVELOPED BY CEMPRA AND IN PHASE III FOR ASTHMA.

  • Clinical Trial
  • Pharmaceutical
  • Respiratory Disease
  • Therapy
  • Mallinckrodt plc
  • ORPHAN AND RARE DERMATOLOGY DRUGS MARKET, GLOBAL, FORECAST REVENUE BY COMPANY (%), 2017-2024
  • 5 Multi-scenario Market Forecast to 2024

Journal of Rare Disease Research and Treatment; ##(##): ##-## ICON (2018).

  • Autoimmune Disease
  • Dermatological Condition
  • Dermatological Treatment
  • Therapy
  • Mallinckrodt plc
  • Mallinckrodt's recent key deals are covered in the following table.

Therapy areas with one pipeline product such as gastrointestinal and genetic disorders are grouped under the other category.

  • Pharmaceutical
  • Therapy
  • Alexion Pharmaceuticals, Inc.
  • Daiichi Sankyo Company
  • Mallinckrodt plc
  • Ophthalmology Therapeutics Market, Global, Forecast Revenues by Company, 2016-2023
  • Ophthalmology Therapeutics Market, Global, Forecast Market Share by Company

The Pharma Innovation; ##(##): ##-## Bresnick GH (1983).

  • Eye Disease
  • Health Services
  • Ophthalmology
  • Therapy
  • Mallinckrodt plc
  • Strategic Consolidations
  • Key Marketed Products

Around ##. ## million (##. ##%) of these patients receive drug therapy of some kind, often including therapy for pain management.

  • Pain Relief
  • Pharmaceutical
  • Therapy
  • Allergan plc
  • Mallinckrodt plc

This can result in intestinal disorders, one of the known risks of broad antibiotic treatment.

  • Infectious Disease
  • Pharmaceutical
  • Therapy
  • United States
  • Mallinckrodt plc
  • 1.4 TREATMENT OPTIONS FOR PAIN
  • APPROVED PHARMACOLOGICAL TREATMENT DRUGS FOR CHRONIC PAIN

Relmada announced positive results from an open-label Phase ## study.

  • Therapy
  • United States
  • World
  • Market Size
  • Mallinckrodt plc
  • ZOGENIX ENTERS INTO CO-PROMOTION AGREEMENT WITH MALLINCKRODT FOR SUMAVEL DOSEPRO
  • ASSET PURCHASE

GlobalData Mallinckrodt LLC, reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Pharmaceutical
  • Therapy
  • United States
  • M&A
  • Mallinckrodt plc
  • SEP 12, 2017: OPEN LETTER TO MALLINCKRODT EMPLOYEES, CUSTOMERS AND PATIENTS REINFORCING IMPORTANT FACTS RELATED TO H.P. ACTHAR GEL AND OTHER MATTERS
  • FEB 14, 2018: MALLINCKRODT ENROLLS FIRST PATIENT IN PHASE 1 STUDY OF EXPRESSGRAFT C9T1 SKIN TISSUE

The Phase ## study is titled " ExpressGraft-C##T## Skin Tissue as a Treatment of Diabetic Foot Ulcers. "

  • Pharmaceutical
  • Therapy
  • United States
  • Company Financials
  • Mallinckrodt plc
  • granted Fast Track Designation for corticotrophin for the treatment of amyotrophic lateral.
  • OCT 26, 2017: MALLINCKRODT PRESENTS MULTIPLE SCLEROSIS RELAPSE DATA AT 7TH JOINT ECTRIMS-ACTRIMS MEETING (MSPARIS2017)

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Neurological Disorder
  • Therapy
  • United States
  • Product Initiative
  • Mallinckrodt plc
  • ZOGENIX ENTERS INTO CO-PROMOTION AGREEMENT WITH MALLINCKRODT FOR SUMAVEL DOSEPRO
  • ASSET PURCHASE

CNS Therapeutics has one marketed product and a diverse pipeline of pain and spasticity products in development.

  • Pharmaceutical
  • Therapy
  • United States
  • M&A
  • Mallinckrodt plc
  • CLINICAL TRIAL PROFILE SNAPSHOTS
  • LATEST CLINICAL TRIALS NEWS ON HEPATORENAL SYNDROME

The safety and efficacy of terlipressin for the treatment of HRS type ## has not been established with the U. S.

  • Clinical Trial
  • Therapy
  • World
  • Product Initiative
  • Mallinckrodt plc
  • DEBT OFFERING
  • Deal Type

Acthar Gel is one.

  • Medical Device
  • Therapy
  • United States
  • Company Financials
  • Mallinckrodt plc
  • MALLINCKRODT LLC, RECENT DEVELOPMENTS
  • SEP 23, 2016: VALIDITY OF MALLINCKRODT'S INOMAX PATENT CLAIMS UPHELD

THERAKOS Systems have been used to deliver over one million photopheresis treatments globally.

  • Therapy
  • United States
  • Litigation And Patent
  • Product Initiative
  • Mallinckrodt plc
  • CAPITAL RAISING - DEAL REPORTS

Partner ## Mallinckrodt, Inc.

  • Therapy
  • United States
  • Company
  • M&A
  • Mallinckrodt plc